Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | ELANE | P08246 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | PGR | P06401 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.44 |
| ▸ | AR | P10275 | 1/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9204152 | 0.89 | LMNA (0.48) | LMNASMN1; SMN2NPC1RAB9AMAPT | |
| SCHEMBL9081470 | 0.86 | LMNA (0.61) | LMNASMN1; SMN2NPC1RAB9AMAPT | |
| SCHEMBL17662334 | 0.85 | LMNA (0.52) | LMNASMN1; SMN2NPC1RAB9AMAPT | |
| SCHEMBL3815839 | 0.85 | SMN1; SMN2 (0.62) | SMN1; SMN2NPC1RAB9AMAPTPOLB | |
| SCHEMBL15164368 | 0.85 | SMN1; SMN2 (0.55) | LMNASMN1; SMN2NPC1RAB9AMAPT | |
| SCHEMBL3392420 | 0.84 | THRB (0.60) | LMNASMN1; SMN2NPC1RAB9AMAPT | |
| SCHEMBL18021005 | 0.84 | LMNA (0.61) | LMNASMN1; SMN2NPC1RAB9AMAPT | |
| SCHEMBL25456089 | 0.82 | SMN1; SMN2 (0.52) | LMNASMN1; SMN2NPC1RAB9AMAPT | |
| SCHEMBL15164370 | 0.82 | SMN1; SMN2 (0.52) | LMNASMN1; SMN2NPC1RAB9AMAPT | |
| SCHEMBL23894744 | 0.82 | LMNA (0.57) | LMNASMN1; SMN2NPC1RAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3833366-B1 | MICROORGANISM MIXTURES, MOLECULES DERIVED THEREFROM, AND METHODS OF USE THEREOF | B G NEGEV TECHNOLOGIES AND APPLICATIONS LTD AT BEN GURION UNIV (IL) | 2025-12-03 | — | — | EP | claimed |
| US-12478610-B2 | Compositions of tryptophol derivatives and 4-ethyl-phenol derivatives, and methods of using same | MALKA, Orit (IL) | 2025-11-25 | — | — | US | claimed |
| EP-4561550-A1 | THERAPEUTIC EFFECT OF MOLECULES DERIVED FROM PROBIOTIC MILK-BASED FERMENTATION MICROBIAL CONSORTIUM (\"KEFIR\") ON WOUNDS HEALING | B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University (IL) | 2025-06-04 | — | — | EP | claimed |
| US-20240041829-A1 | METHODS FOR MODULATING MICROBIAL POPULATIONS | BAR-ILAN UNIVERSITY (IL) | 2024-02-08 | — | — | US | claimed |
| EP-4267120-A1 | METHODS FOR MODULATING MICROBIAL POPULATIONS | B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University (IL) | 2023-11-01 | — | — | EP | claimed |
| CN-116672274-A | Use of sweetsop fermentation liquor for preparing composition for inhibiting melanin generation and improving immune cell antioxidant capacity | 百岳特生物技术（上海）有限公司 | 2023-09-01 | — | — | CN | claimed |
| US-20230172905-A1 | COMPOSITIONS OF TRYPTOPHOL DERIVATIVES AND 4-ETHYL-PHENOL DERIVATIVES, AND METHODS OF USING SAME | B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (IL) | 2023-06-08 | — | — | US | claimed |
| EP-4149458-A1 | COMPOSITIONS OF TRYPTOPHOL DERIVATIVES AND 4-ETHYL-PHENOL DERIVATIVES, AND METHODS OF USING SAME | B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University (IL) | 2023-03-22 | — | — | EP | claimed |
| WO-2022137239-A1 | METHODS FOR MODULATING MICROBIAL POPULATIONS | B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (IL) | 2022-06-30 | — | — | WO | claimed |
| US-20220160680-A1 | MICROORGANISM MIXTURES, MOLECULES DERIVED THEREFROM, AND METHODS OF USE THEREOF | B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (IL) | 2022-05-26 | — | — | US | claimed |
| EP-3833366-B1 | MICROORGANISM MIXTURES, MOLECULES DERIVED THEREFROM, AND METHODS OF USE THEREOF | B G NEGEV TECHNOLOGIES AND APPLICATIONS LTD AT BEN GURION UNIV (IL) | 2025-12-03 | — | — | EP | disclosed |
| US-12478610-B2 | Compositions of tryptophol derivatives and 4-ethyl-phenol derivatives, and methods of using same | MALKA, Orit (IL) | 2025-11-25 | — | — | US | disclosed |
| EP-4561550-A1 | THERAPEUTIC EFFECT OF MOLECULES DERIVED FROM PROBIOTIC MILK-BASED FERMENTATION MICROBIAL CONSORTIUM (\"KEFIR\") ON WOUNDS HEALING | B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University (IL) | 2025-06-04 | — | — | EP | disclosed |
| CN-114195640-B | Synthesis process of hydroxytyrosol and intermediate thereof | 攀枝花学院 | 2024-03-12 | — | — | CN | disclosed |
| US-20240041829-A1 | METHODS FOR MODULATING MICROBIAL POPULATIONS | BAR-ILAN UNIVERSITY (IL) | 2024-02-08 | — | — | US | disclosed |
| EP-0625971-A1 | UV LIGHT STABILIZING, ANTIOXIDANT AND COLORANT COMPOUNDS | HOECHST CELANESE CORPORATION (US) | 1994-11-30 | — | — | EP | disclosed |
| US-5247124-A | Process for the preparation of substituted styrenes | HOECHST CELANESE CORPORATION (US) | 1993-09-21 | — | — | US | disclosed |
| WO-1993015063-A1 | UV LIGHT STABILIZING, ANTIOXIDANT AND COLORANT COMPOUNDS | HOECHST CELANESE CORPORATION (US) | 1993-08-05 | — | — | WO | disclosed |
| US-5210278-A | Process for the preparation of bisarylalkyl ethers | HOECHST CELANESE CORPORATION (US) | 1993-05-11 | — | — | US | disclosed |
| US-5194672-A | Process for the preparation of substituted styrenes | HOECHST CELANESE CORPORATION (US) | 1993-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12478610-B2 | Compositions of tryptophol derivatives and 4-ethyl-phenol derivatives, and methods of using same | F2, TYR, TH | LMNA 1871/4885SMN1; SMN2 4343/4885NPC1 4489/4885 |
| US-20220160680-A1 | MICROORGANISM MIXTURES, MOLECULES DERIVED THEREFROM, AND METHODS OF USE THEREOF | COMT, TH, TDO2 | LMNA 3885/4885SMN1; SMN2 4812/4885NPC1 4369/4885 |
| US-20230172905-A1 | COMPOSITIONS OF TRYPTOPHOL DERIVATIVES AND 4-ETHYL-PHENOL DERIVATIVES, AND METHODS OF USING SAME | F2, TYR, TH | LMNA 1871/4885SMN1; SMN2 4343/4885NPC1 4489/4885 |
| US-20240041829-A1 | METHODS FOR MODULATING MICROBIAL POPULATIONS | TYR, TPH2, IDO2 | LMNA 4154/4885SMN1; SMN2 4863/4885NPC1 3820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.